Srdan Verstovsek, MD, PhD

Dr. Verstovsek is Professor in the Department of Leukemia, Director of the Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms, and Chief of the Section for Myeloproliferative Neoplasms at the MD Anderson Cancer Center in Houston.

Articles by Srdan Verstovsek, MD, PhD

Srdan Verstovsek, MD, on Predicting Resistance to Hydroxyurea Therapy in Polycythemia Vera

Leah SherwoodMeeting News | May 30, 2023

Srdan Verstovsek, MD, discusses using machine learning to predict resistance to hydroxyurea therapy in polycythemia vera.

The HemOnc Pulse Live at ASH: Srdan Verstovsek, MD, on MPN Treatment Combinations, Timing

Chadi Nabhan, MD, MBA, FACPVideo Insights | January 10, 2023

Chadi Nabhan, MD, MBA, FACP, interviews Srdan Verstovsek, MD, on highlights in MPN research at the 2022 ASH Annual Meeting.

Srdan Verstovsek, MD, on the Phase III VERIFY Trial

Leah SherwoodVideo Insights | May 30, 2023

Srdan Verstovsek, MD, discusses the phase III VERIFY trial of rusfertide in patients with polycythemia vera.

State of the Art: Novel Therapies for Myelofibrosis

Helen T. Chifotides, PhDMyelofibrosis | January 21, 2022

Experts discuss emerging therapeutic targets, the impact of recently approved agents, and incorporating them into practice.